These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26181819)

  • 1. Oral Lopinavir Use and Human Papillomavirus Infection in HIV-Positive Women.
    Lahiri CD; Dugan KB; Xie X; Reimers L; Burk RD; Anastos K; Massad LS; Eltoum IE; Xue X; DʼSouza G; Flowers L; Palefsky JM; Rahangdale L; Strickler HD; Ofotokun I
    J Acquir Immune Defic Syndr; 2015 Oct; 70(2):e63-6. PubMed ID: 26181819
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cancer and human immunodeficiency virus in the era of combination therapy].
    Núñez M; Soriano V
    Med Clin (Barc); 2000 Jun; 115(3):93-4. PubMed ID: 10965483
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases.
    Heard I; Palefsky JM; Kazatchkine MD
    Antivir Ther; 2004 Feb; 9(1):13-22. PubMed ID: 15040532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of highly active antiretroviral therapy in human papillomavirus-induced genital dysplasia in HIV-1-infected patients.
    Orlando G; Fasolo MM; Schiavini M; Signori R; Cargnel A
    AIDS; 1999 Feb; 13(3):424-5. PubMed ID: 10199237
    [No Abstract]   [Full Text] [Related]  

  • 5. The need to revolutionize our approach to women coinfected with HIV and HPV.
    Biggers S
    AIDS Read; 2000 Dec; 10(12):692. PubMed ID: 11189734
    [No Abstract]   [Full Text] [Related]  

  • 6. Cervical neoplasia and highly active antiretroviral therapy.
    Xi LF; Kiviat NB
    J Natl Cancer Inst; 2004 Jul; 96(14):1051-3. PubMed ID: 15265960
    [No Abstract]   [Full Text] [Related]  

  • 7. Human papillomavirus and the risk of cervical cancer.
    Burk RD
    Hosp Pract (1995); 1999 Nov; 34(12):103-11; quiz 112. PubMed ID: 10616548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of cervical abnormalities among HIV-infected African women.
    Folkers G
    NIAID AIDS Agenda; 1996 Jun; ():9, 11. PubMed ID: 11363811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus infection. Recent findings on progression to cervical cancer.
    Adimora AA; Quinlivan EB
    Postgrad Med; 1995 Sep; 98(3):109-12, 115-6, 120. PubMed ID: 7675735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress and pitfalls in defining the influence of highly active antiretroviral therapy on human papillomavirus-associated cervical disease.
    Gravitt PE; Kirk GD
    J Infect Dis; 2010 Mar; 201(5):650-2. PubMed ID: 20105079
    [No Abstract]   [Full Text] [Related]  

  • 11. [Human papillomavirus and human immunodeficiency virus infections as risk factors for cervix cancer in women prisoners].
    de Sanjosé S; Valls I; Paz Cañadas M; Lloveras B; Quintana MJ; Shah KV; Bosch FX
    Med Clin (Barc); 2000 Jun; 115(3):81-4. PubMed ID: 10965480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correspondence re: J. S. Mandelblatt et al., Is HIV infection a cofactor for cervical squamous cell neoplasia? Cancer Epidemiol. Biomark. Prev., 8: 97-106, 1999.
    La Ruche G; You B; Leroy V; Welffens-Ekra C; Dabis F
    Cancer Epidemiol Biomarkers Prev; 1999 Aug; 8(8):729-30. PubMed ID: 10744135
    [No Abstract]   [Full Text] [Related]  

  • 13. Anal human papillomavirus and anal cancer.
    Tilston P
    J Clin Pathol; 1997 Aug; 50(8):625-34. PubMed ID: 9301544
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cervix dysplasia and cervix carcinoma].
    Bol P
    Ned Tijdschr Tandheelkd; 1998 Dec; 105(12):455-6. PubMed ID: 11928150
    [No Abstract]   [Full Text] [Related]  

  • 15. Human papillomavirus type-specific risk of cervical cancer in a population with high human immunodeficiency virus prevalence: case-control study.
    Naucler P; Mabota da Costa F; da Costa JL; Ljungberg O; Bugalho A; Dillner J
    J Gen Virol; 2011 Dec; 92(Pt 12):2784-2791. PubMed ID: 21900420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of cervical disease in HIV-infected women.
    Denny L; Walraven S; Myer L; Allan B; Williamson A
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S14-5. PubMed ID: 16419184
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
    Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
    PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection.
    Lillo FB; Lodini S; Ferrari D; Stayton C; Taccagni G; Galli L; Lazzarin A; Uberti-Foppa C
    Clin Infect Dis; 2005 Feb; 40(3):451-7. PubMed ID: 15668870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of gynecological conditions in women.
    Proj Inf Perspect; 1998 Sep; (25):15. PubMed ID: 11365842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus genotype distribution and human papillomavirus 16 and human papillomavirus 18 genomic integration in invasive and in situ cervical carcinoma in human immunodeficiency virus-infected women.
    Darwich L; Cañadas MP; Sirera G; Alameda F; Forcada P; Delas J; Fernández I; Llatjós M; Coll J; Clotet B; Videla S
    Int J Gynecol Cancer; 2011 Nov; 21(8):1486-90. PubMed ID: 21892092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.